Back to News
Market Impact: 0.3
$CAPR Stock Notification: Capricor Therapeutics has been Sued for Securities Fraud after Clinical Data Issues Disclosed – Investors are Alerted to Contact BFA Law by September 28
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Capricor Therapeutics faces a securities-fraud lawsuit following disclosed clinical-data issues, with investors urged to contact BFA Law by September 28. The litigation raises potential legal, regulatory, and investor-confidence risks for the biotechnology company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.65
Ticker Sentiment
CAPR-0.90
More News
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- US aviation sanctions disrupt Iran flights, push travellers overland
- Australia says OpenAI agent hacked Medicare portal
- Meta Debuts $349 Camera-Free Ray-Bans and Brings Muse to Glasses
- How Meta took the lead in the race for the post-smartphone world
- OpenAI agents ‘infiltrated Australian government website’